IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 132 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $216,886 | -17.4% | 20,384 | -18.3% | 0.04% | -20.4% |
| Q1 2023 | $262,569 | -41.7% | 24,959 | -31.3% | 0.05% | -54.6% |
| Q4 2022 | $450,092 | +210.4% | 36,327 | +159.8% | 0.11% | +227.3% |
| Q3 2022 | $145,000 | -71.2% | 13,984 | -68.0% | 0.03% | -75.7% |
| Q2 2022 | $504,000 | +130.1% | 43,693 | +132.2% | 0.14% | +81.3% |
| Q4 2021 | $219,000 | -28.9% | 18,816 | -20.3% | 0.08% | -25.0% |
| Q3 2021 | $308,000 | +96.2% | 23,616 | +94.1% | 0.10% | +53.8% |
| Q2 2021 | $157,000 | +6.8% | 12,166 | -5.4% | 0.06% | -27.8% |
| Q4 2020 | $147,000 | +22.5% | 12,866 | +10.2% | 0.09% | -40.8% |
| Q2 2020 | $120,000 | -51.8% | 11,676 | -13.5% | 0.15% | -10.1% |
| Q3 2018 | $249,000 | +1.6% | 13,500 | -6.1% | 0.17% | -73.3% |
| Q1 2017 | $245,000 | -41.9% | 14,383 | -58.9% | 0.63% | +75.6% |
| Q2 2015 | $422,000 | – | 34,980 | – | 0.36% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rubric Capital Management, LLC | 6,422,200 | $74,433,000 | 6.49% |
| SECTOR GAMMA AS | 1,974,421 | $22,884,000 | 5.88% |
| BVF INC/IL | 2,935,975 | $34,028,000 | 5.80% |
| Redmile Group, LLC | 3,671,344 | $42,551,000 | 3.18% |
| EcoR1 Capital, LLC | 821,531 | $9,522,000 | 2.99% |
| BRIDGER MANAGEMENT, LLC | 4,944,594 | $57,308,000 | 1.89% |
| Orbimed Advisors | 11,226,400 | $130,114,000 | 1.18% |
| Broderick Brian C | 156,345 | $1,812,000 | 0.81% |
| Lombard Odier Asset Management (USA) Corp | 602,271 | $6,980,000 | 0.68% |
| EverPoint Asset Management, LLC | 2,350,000 | $27,237,000 | 0.57% |